Influence of selective estrogen receptor modulators on interleukin-6 expression in human retinal pigment epithelial cells (ARPE-19).
暂无分享,去创建一个
A. Salminen | H. Uusitalo | K. Kaarniranta | M. Karvonen | M. Unkila | J. Hyttinen | T. Ryhänen | J. Viiri | T. Paimela
[1] E. Souied,et al. [Epidemiology of age related macular degeneration]. , 2009, Journal francais d'ophtalmologie.
[2] S. Kyrylenko,et al. Regulation of ERα Signaling Pathway in Neuronal HN10 Cells: Role of Protein Acetylation and Hsp90 , 2008, Neurochemical Research.
[3] Joe G Hollyfield,et al. Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.
[4] A. Salminen,et al. The effect of 17β-estradiol on IL-6 secretion and NF-κB DNA-binding activity in human retinal pigment epithelial cells , 2007 .
[5] J. V. van Meurs,et al. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. , 2007, Investigative ophthalmology & visual science.
[6] R. Klein,et al. Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study. , 2006, Archives of ophthalmology.
[7] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[8] B. Rosner,et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.
[9] G. Abecasis,et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.
[10] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[11] D. Kalaitzidis,et al. Transcription factor cross-talk: the estrogen receptor and NF-κB , 2005, Trends in Endocrinology & Metabolism.
[12] B. Munoz,et al. Hormone Replacement Therapy, Reproductive Factors, and Age-Related Macular Degeneration: The Salisbury Eye Evaluation Project , 2005, Ophthalmic epidemiology.
[13] C. García-Moreno,et al. Effects of 17β-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-β1 and insulin-like growth factor-1 in primary human osteoblast cultures , 2004, Journal of endocrinological investigation.
[14] D. Solit,et al. Hsp90: the vulnerable chaperone. , 2004, Drug discovery today.
[15] M. Chin,et al. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells , 2004, Journal of Neuroimmunology.
[16] M. Zarbin. Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.
[17] A. Maran,et al. ER-independent actions of estrogen and estrogen metabolites in bone cells. , 2003, Journal of musculoskeletal & neuronal interactions.
[18] Myles Brown,et al. Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy , 2003, Breast Cancer Research.
[19] B. Evans,et al. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. , 2003, The Journal of endocrinology.
[20] L. Hartmann,et al. Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. , 2003, The New England journal of medicine.
[21] W. Pratt,et al. Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery 1 , 2003, Experimental biology and medicine.
[22] Donald P. McDonnell,et al. Connections and Regulation of the Human Estrogen Receptor , 2002, Science.
[23] Myles Brown,et al. Molecular Determinants for the Tissue Specificity of SERMs , 2002, Science.
[24] E. Jackson,et al. Invited Review: Cardiovascular protective effects of 17β-estradiol metabolites , 2001 .
[25] J. Rakic,et al. Presence of oestrogen receptor type β in human retina , 2001, The British journal of ophthalmology.
[26] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[27] D. Farber,et al. Estrogen receptor in the human eye: influence of gender and age on gene expression. , 1999, Investigative ophthalmology & visual science.
[28] S. Cowley,et al. A comparison of transcriptional activation by ERα and ERβ , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[29] B. Katzenellenbogen,et al. Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.). , 1998, Endocrinology.
[30] E. Baulieu,et al. The 90 kDa heat-shock protein (hsp90) modulates the binding of the oestrogen receptor to its cognate DNA. , 1996, The Biochemical journal.
[31] L. Hjelmeland,et al. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. , 1996, Experimental eye research.
[32] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[33] A. Salminen,et al. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. , 2007, Immunology letters.
[34] D. Kalaitzidis,et al. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. , 2005, Trends in endocrinology and metabolism: TEM.
[35] R. Schiff,et al. Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] Scott W Cousins,et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. , 2003, Investigative ophthalmology & visual science.
[37] E. Jackson,et al. Cardiovascular protective effects of 17beta-estradiol metabolites. , 2001, Journal of applied physiology.
[38] S. Cowley,et al. A comparison of transcriptional activation by ER alpha and ER beta. , 1999, The Journal of steroid biochemistry and molecular biology.
[39] B S Hawkins,et al. Epidemiology of age-related macular degeneration. , 1999, Molecular vision.
[40] J. Gustafsson,et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.